Product Information
PALIPERIDONE ER 9 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $1.2437 per EA under NDC 31722032030. Its NADAC has been published 116 times since Apr 10, 2024.
Strength
9 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722032030
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PALIPERIDONEApproval Type
Generic (ANDA)
FDA Application
ANDA216174On Market Since
8/23/2023
Pharmacological Classes
Price Statistics
The NADAC for PALIPERIDONE ER 9 MG TABLET has been published 116 times since Apr 10, 2024, and over the history we have for it it has declined 35.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2437 per EA |
|---|---|
| All-time high | $2.3932 (Sep 11, 2024) |
| All-time low | $1.2437 (Jun 17, 2026) |
| 52-week high | $1.6995 |
| 52-week low | $1.2437 |
| Median price | $1.6275 |
| Average price | $1.6481 |
| Largest weekly change | +65.2% (Aug 21, 2024) |
| Weeks tracked | 116 |
| Tracking since | Apr 10, 2024 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PALIPERIDONE ER 9 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PALIPERIDONE ER 9 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $1.2437 per EA (NDC 31722032030), effective Jun 24, 2026.
How has the price of PALIPERIDONE ER 9 MG TABLET changed over time?
Over the history we have for it, the NADAC for PALIPERIDONE ER 9 MG TABLET has declined 35.8%. It has been tracked across 116 weekly CMS publications since Apr 10, 2024.
What are the highest and lowest recorded NADAC prices for PALIPERIDONE ER 9 MG TABLET?
Since Apr 10, 2024, the NADAC for PALIPERIDONE ER 9 MG TABLET has ranged from a low of $1.2437 (Jun 17, 2026) to a high of $2.3932 (Sep 11, 2024), with a median of $1.6275 per EA.
Are there cheaper alternatives to PALIPERIDONE ER 9 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as PALIPERIDONE ER 9 MG TABLET, but none are currently priced below it.
Who manufactures PALIPERIDONE ER 9 MG TABLET?
PALIPERIDONE ER 9 MG TABLET (NDC 31722032030) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification